Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Randomized Clinical Study to Evaluate the Clinical Impact of Pharmacogenetic-Guided Treatment for Depression & Anxiety

NCT02878928 is registered in ClinicalTrials.gov with AltheaDx as lead sponsor.

NCT NCT02878928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02878928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Randomized Clinical Study to Evaluate the Clinical Impact of Pharmacogenetic-Guided Treatment for Depression & Anxiety
Lead sponsor
AltheaDx
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
December 31, 2016
Enrollment
579 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression